These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33469937)

  • 21. Anatomical Distribution of Ochronotic Pigment in Alkaptonuric Mice is Associated with Calcified Cartilage Chondrocytes at Osteochondral Interfaces.
    Hughes JH; Keenan CM; Sutherland H; Edwards HR; Wilson PJM; Ranganath LR; Jarvis JC; Bou-Gharios G; Gallagher JA
    Calcif Tissue Int; 2021 Feb; 108(2):207-218. PubMed ID: 33057760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homogentisic acid affects human osteoblastic functionality by oxidative stress and alteration of the Wnt/β-catenin signaling pathway.
    Schiavone ML; Millucci L; Bernardini G; Giustarini D; Rossi R; Marzocchi B; Santucci A
    J Cell Physiol; 2020 Oct; 235(10):6808-6816. PubMed ID: 31989660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutritional interventions for patients with alkaptonuria: A minireview.
    Imrich R; Zatkova A; Lukacova O; Sedlakova J; Zanova E; Vlcek M; Penesova A; Radikova Z; Havranova A; Ranganath L
    Endocr Regul; 2023 Jan; 57(1):61-67. PubMed ID: 36966367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria.
    Ranganath LR; Milan AM; Hughes AT; Khedr M; Davison AS; Shweihdi E; Norman BP; Hughes JH; Bygott H; Luangrath E; Fitzgerald R; Psarelli EE; van Kan C; Laan D; Olsson B; Rudebeck M; Mankowitz L; Sireau N; Arnoux JB; Le Quan Sang KH; Jarvis JC; Genovese F; Braconi D; Santucci A; Zatkova A; Glasova H; Stančík R; Imrich R; Rhodes NP; Gallagher JA
    J Inherit Metab Dis; 2020 Jul; 43(4):737-747. PubMed ID: 31609457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of alkaptonuria revisited: analyses based on scoring systems.
    Ranganath LR; Cox TF
    J Inherit Metab Dis; 2011 Dec; 34(6):1141-51. PubMed ID: 21748407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R
    Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
    Ranganath LR; Khedr M; Milan AM; Davison AS; Hughes AT; Usher JL; Taylor S; Loftus N; Daroszewska A; West E; Jones A; Briggs M; Fisher M; McCormick M; Judd S; Vinjamuri S; Griffin R; Psarelli EE; Cox TF; Sireau N; Dillon JP; Devine JM; Hughes G; Harrold J; Barton GJ; Jarvis JC; Gallagher JA
    Mol Genet Metab; 2018 Sep; 125(1-2):127-134. PubMed ID: 30055994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaptonuria: clinical manifestations and an updated approach to treatment of a rare disease.
    Roopnarinesingh RC; Donlon NE; Reynolds JV
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34876442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new light on Alkaptonuria: A Fourier-transform infrared microscopy (FTIRM) and low energy X-ray fluorescence (LEXRF) microscopy correlative study on a rare disease.
    Mitri E; Millucci L; Merolle L; Bernardini G; Vaccari L; Gianoncelli A; Santucci A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1000-1008. PubMed ID: 28192171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor β-induced superficial zone protein accumulation in the surface zone of articular cartilage is dependent on the cytoskeleton.
    McNary SM; Athanasiou KA; Reddi AH
    Tissue Eng Part A; 2014 Mar; 20(5-6):921-9. PubMed ID: 24116978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Untargeted NMR Metabolomics Reveals Alternative Biomarkers and Pathways in Alkaptonuria.
    Grasso D; Geminiani M; Galderisi S; Iacomelli G; Peruzzi L; Marzocchi B; Santucci A; Bernini A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform.
    Milella MS; Geminiani M; Trezza A; Visibelli A; Braconi D; Santucci A
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy.
    Zaib S; Rana N; Hussain N; Ogaly HA; Dera AA; Khan I
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disassembly of the vimentin cytoskeleton disrupts articular cartilage chondrocyte homeostasis.
    Blain EJ; Gilbert SJ; Hayes AJ; Duance VC
    Matrix Biol; 2006 Sep; 25(7):398-408. PubMed ID: 16876394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine homogentisic acid and tyrosine: simultaneous analysis by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Christensen P; Ross G; Davison AS; Gallagher JA; Dutton JJ; Ranganath LR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():106-12. PubMed ID: 24952314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria.
    Norman BP; Sutherland H; Wilson PJM; Rutland DA; Milan AM; Hughes AT; Davison AS; Khedr M; Jarvis JC; Gallagher JA; Bou-Gharios G; Ranganath LR
    J Inherit Metab Dis; 2024 Jul; 47(4):664-673. PubMed ID: 38487984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems.
    Cox TF; Ranganath L
    J Inherit Metab Dis; 2011 Dec; 34(6):1153-62. PubMed ID: 21744089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological and Ultrastructural Characterization of Alkaptonuric Tissues.
    Millucci L; Bernardini G; Spreafico A; Orlandini M; Braconi D; Laschi M; Geminiani M; Lupetti P; Giorgetti G; Viti C; Frediani B; Marzocchi B; Santucci A
    Calcif Tissue Int; 2017 Jul; 101(1):50-64. PubMed ID: 28271171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an in vitro model to investigate joint ochronosis in alkaptonuria.
    Tinti L; Taylor AM; Santucci A; Wlodarski B; Wilson PJ; Jarvis JC; Fraser WD; Davidson JS; Ranganath LR; Gallagher JA
    Rheumatology (Oxford); 2011 Feb; 50(2):271-7. PubMed ID: 20952450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.
    Introne WJ; Phornphutkul C; Bernardini I; McLaughlin K; Fitzpatrick D; Gahl WA
    Mol Genet Metab; 2002; 77(1-2):136-42. PubMed ID: 12359141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.